Product Information

METRONIDAZOLE 250 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1237 per EA under NDC 62135079590. Its NADAC has been published 137 times since Apr 10, 2024.

FDA first approved this application on Sep 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

METRONIDAZOLE 250 MG TABLET

Metronidazole
$0.1237per EA
High Outlier

Strength

250 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135079590

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METRONIDAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA205245

FDA Approved

9/23/2015

TE Code

AB

On Market Since

11/29/2017

Pharmacological Classes

Price Statistics

The NADAC for METRONIDAZOLE 250 MG TABLET has been published 137 times since Apr 10, 2024, and over the history we have for it it has risen 20.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1237 per EA
All-time high$0.1239 (Oct 16, 2024)
All-time low$0.0623 (Dec 17, 2025)
52-week high$0.1237
52-week low$0.0623
Median price$0.0950
Average price$0.0930
Largest weekly change+35.7% (Sep 18, 2024)
Weeks tracked137
Tracking sinceApr 10, 2024

Price History

1W

+14.7%

1M

+21.7%

3M

+15.8%

6M

+47.6%

1Y

+70.8%

3Y

N/A

5Y

N/A

All

+20.9%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METRONIDAZOLE 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Chartwell RX LLC, is $0.1237 per EA (NDC 62135079590), effective Nov 18, 2026.

How has the price of METRONIDAZOLE 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has risen 20.9%. It has been tracked across 137 weekly CMS publications since Apr 10, 2024.

What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?

Since Apr 10, 2024, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.1239 (Oct 16, 2024), with a median of $0.0950 per EA.

Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE 250 MG TABLET, is $0.0970 per EA — about 22% below METRONIDAZOLE 250 MG TABLET.

Who manufactures METRONIDAZOLE 250 MG TABLET?

METRONIDAZOLE 250 MG TABLET (NDC 62135079590) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.